锌补充在多囊卵巢综合征治疗中的作用:机制与临床证据
The Role of Zinc Supplementation in the Treatment of Polycystic Ovary Syndrome: Mechanisms and Clinical Evidence
DOI: 10.12677/acm.2026.161164, PDF,   
作者: 吕迎春:黑龙江中医药大学研究生院,黑龙江 哈尔滨;匡洪影*:黑龙江中医药大学附属第一医院妇科二科,黑龙江 哈尔滨
关键词: 多囊卵巢综合征锌补充胰岛素抵抗Polycystic Ovary Syndrome Zinc Zinc Supplementation Insulin Resistance
摘要: 多囊卵巢综合征(polycystic ovary syndrome, PCOS)是常见的一种内分泌代谢紊乱疾病,临床表现高度异质性,以雄激素过量、排卵功能障碍和卵巢多囊样改变为主要特征。近年来,锌稳态在PCOS病理生理过程中的作用日益受到关注。本文系统综述了锌在PCOS卵泡发育、胰岛素抵抗、氧化应激和雄激素过量中的核心作用机制,评估了锌补充在改善PCOS代谢异常、内分泌紊乱和生殖功能障碍中的治疗潜力,并探讨了未来研究方向及临床转化面临的挑战。现有证据表明,锌稳态失衡是PCOS病理生理过程中的一个重要环节,而补锌可能成为改善PCOS症状的潜在治疗策略,为开发基于锌稳态调节的PCOS精准防治提供了新思路。
Abstract: Polycystic ovary syndrome (PCOS) is a common endocrine metabolic disorder characterized by high clinical heterogeneity, primarily manifested as hyperandrogenism, ovulatory dysfunction, and polycystic ovarian changes. In recent years, the role of zinc homeostasis in the pathophysiological processes of PCOS has garnered increasing attention. This systematic review examines zinc’s core mechanisms in PCOS follicular development, insulin resistance, oxidative stress, and hyperandrogenism. It evaluates zinc supplementation’s therapeutic potential for improving PCOS metabolic abnormalities, endocrine dysfunction, and reproductive disorders, while exploring future research directions and challenges in clinical translation. Existing evidence indicates that zinc homeostasis imbalance is a critical component in the pathophysiological process of PCOS, and zinc supplementation may emerge as a potential therapeutic strategy for alleviating PCOS symptoms. This provides new insights for developing precision prevention and treatment strategies for PCOS based on zinc homeostasis regulation.
文章引用:吕迎春, 匡洪影. 锌补充在多囊卵巢综合征治疗中的作用:机制与临床证据[J]. 临床医学进展, 2026, 16(1): 1267-1276. https://doi.org/10.12677/acm.2026.161164

参考文献

[1] Helvaci, N. and Yildiz, B.O. (2025) Polycystic Ovary Syndrome as a Metabolic Disease. Nature Reviews Endocrinology, 21, 230-244. [Google Scholar] [CrossRef] [PubMed]
[2] Chen, B., Yu, P., Chan, W.N., Xie, F., Zhang, Y., Liang, L., et al. (2024) Cellular Zinc Metabolism and Zinc Signaling: From Biological Functions to Diseases and Therapeutic Targets. Signal Transduction and Targeted Therapy, 9, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[3] Camp, O.G., Moussa, D.N., Hsu, R., Awonuga, A.O. and Abu-Soud, H.M. (2024) The Interplay between Oxidative Stress, Zinc, and Metabolic Dysfunction in Polycystic Ovarian Syndrome. Molecular and Cellular Biochemistry, 480, 2015-2023. [Google Scholar] [CrossRef] [PubMed]
[4] Abedini, M., Ghaedi, E., Hadi, A., Mohammadi, H. and Amani, R. (2019) Zinc Status and Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis. Journal of Trace Elements in Medicine and Biology, 52, 216-221. [Google Scholar] [CrossRef] [PubMed]
[5] Yin, J., Hong, X., Ma, J., Bu, Y. and Liu, R. (2020) Serum Trace Elements in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology, 11, Article ID: 572384. [Google Scholar] [CrossRef] [PubMed]
[6] Guler, I., Himmetoglu, O., Turp, A., Erdem, A., Erdem, M., Onan, M.A., et al. (2014) Zinc and Homocysteine Levels in Polycystic Ovarian Syndrome Patients with Insulin Resistance. Biological Trace Element Research, 158, 297-304. [Google Scholar] [CrossRef] [PubMed]
[7] Kang, Y., Zhao, J. and Liu, J. (2025) Zinc Sulfate Improves Insulin Resistance, Oxidative Stress and Apoptosis in Liver Tissues of PCOS Rats through the NF-κB Pathway. Frontiers in Endocrinology, 16, Article ID: 1569866. [Google Scholar] [CrossRef] [PubMed]
[8] Liao, X., Wu, L., Yin, D., Tian, D., Zhou, C., Liu, J., et al. (2023) The Role of Zinc in Follicular Development. Molecular Biology Reports, 50, 4527-4534. [Google Scholar] [CrossRef] [PubMed]
[9] Hester, J.M. and Diaz, F.J. (2025) DTPA Disrupts Development of Preantral Ovarian Follicles in Vitro. Reproduction and Fertility, 6, e240125. [Google Scholar] [CrossRef
[10] Janati, S., Behmanesh, M.A., Najafzadehvarzi, H., et al. (2021) Follicular Fluid Zinc Level and Oocyte Maturity and Embryo Quality in Women with Polycystic Ovary Syndrome. International Journal of Fertility & Sterility, 15, 197-201.
[11] Lai, X., Xiong, W., Li, L., Lan, M., Zhang, J., Zhou, Y., et al. (2023) Zinc Deficiency Compromises the Maturational Competence of Porcine Oocyte by Inducing Mitophagy and Apoptosis. Ecotoxicology and Environmental Safety, 252, Article 114593. [Google Scholar] [CrossRef] [PubMed]
[12] Dong, Z., Zhang, L., Wang, W., Jiang, F. and Ai, H. (2023) Znso4 Protects against Premature Ovarian Failure through PI3K/AKT/GSK3β Signaling Pathway. Theriogenology, 207, 61-71. [Google Scholar] [CrossRef] [PubMed]
[13] Liu, W., Li, L., Lan, M., Shang, J., Zhang, J., Xiong, W., et al. (2024) Zinc Deficiency Deteriorates Ovarian Follicle Development and Function by Inhibiting Mitochondrial Function. Journal of Ovarian Research, 17, Article No. 115. [Google Scholar] [CrossRef] [PubMed]
[14] Li, X., Zhao, Q., Lin, G. and Xu, L. (2025) The Auxiliary Effect of Oral Nutritional Supplements on Fertility in Women with Diminished Ovarian Reserve: A Systematic Review and Meta-Analysis. Annals of Medicine, 57, Article 2583330. [Google Scholar] [CrossRef
[15] Nakamura, A., Kido, T., Seki, Y. and Suka, M. (2024) Zinc Deficiency Affects Insulin Secretion and Alters Insulin-Regulated Metabolic Signaling in Rats. Journal of Trace Elements in Medicine and Biology, 83, Article 127375. [Google Scholar] [CrossRef] [PubMed]
[16] Hashemipour, M., Kelishadi, R., Shapouri, J., Sarrafzadegan, N., Amini, M., Tavakoli, N., et al. (2009) Effect of Zinc Supplementation on Insulin Resistance and Components of the Metabolic Syndrome in Prepubertal Obese Children. Hormones, 8, 279-285. [Google Scholar] [CrossRef] [PubMed]
[17] Foroozanfard, F., Jamilian, M., Jafari, Z., Khassaf, A., Hosseini, A., Khorammian, H., et al. (2015) Effects of Zinc Supplementation on Markers of Insulin Resistance and Lipid Profiles in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Experimental and Clinical Endocrinology & Diabetes, 123, 215-220. [Google Scholar] [CrossRef] [PubMed]
[18] Fazel Torshizi, F., Chamani, M., Khodaei, H.R., et al. (2020) Therapeutic Effects of Organic Zinc on Reproductive Hormones, Insulin Resistance and mTOR Expression, as a Novel Component, in a Rat Model of PCOS. Iranian Journal of Basic Medical Sciences, 23, 36-45.
[19] Motta, A.B. (2024) Polycystic Ovary Syndrome and Oxidative Stress. Natural Treatments. Current Medicinal Chemistry, 32, 1457-1468.
[20] Orisaka, M., Mizutani, T., Miyazaki, Y., Shirafuji, A., Tamamura, C., Fujita, M., et al. (2023) Chronic Low-Grade Inflammation and Ovarian Dysfunction in Women with Polycystic Ovarian Syndrome, Endometriosis, and Aging. Frontiers in Endocrinology, 14, Article ID: 1324429. [Google Scholar] [CrossRef] [PubMed]
[21] Szuster-Ciesielska, A., Plewka, K., Daniluk, J. and Kandefer-Szerszeń, M. (2009) Zinc Supplementation Attenuates Ethanol-and Acetaldehyde-Induced Liver Stellate Cell Activation by Inhibiting Reactive Oxygen Species (ROS) Production and by Influencing Intracellular Signaling. Biochemical Pharmacology, 78, 301-314. [Google Scholar] [CrossRef] [PubMed]
[22] Jin, H., Zhu, X., Zhang, M., Zheng, H., Chen, Y., Yao, D., et al. (2025) Cu/Zn/Histidine Supramolecular Assemblies with Optimized Cu Catalytic Sites as an Alternative of Superoxide Dismutase. Nature Communications, 16, Article No. 10075. [Google Scholar] [CrossRef
[23] Jamilian, M., Foroozanfard, F., Bahmani, F., Talaee, R., Monavari, M. and Asemi, Z. (2016) Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Biological Trace Element Research, 170, 271-278. [Google Scholar] [CrossRef] [PubMed]
[24] Camp, O.G., Bembenek, J.N., Goud, P.T., Awonuga, A.O. and Abu-Soud, H.M. (2023) The Implications of Insufficient Zinc on the Generation of Oxidative Stress Leading to Decreased Oocyte Quality. Reproductive Sciences, 30, 2069-2078. [Google Scholar] [CrossRef] [PubMed]
[25] Mohammed, N.A., Sulaiman, G.M. and Alabassi, H.M. (2025) Importance of Lactate Dehydrogenase, Cortisol, Dopamine, Zinc, and Vitamin D3 in Iraqi Patients with Polycystic Ovary Syndrome. Iraqi Journal of Science, 66, 546-560. [Google Scholar] [CrossRef
[26] Aliyev, U., Pehlivantürk-Kızılkan, M., Düzçeker, Y., Kanbur, N., Aycan, Z., Akgül, S., et al. (2020) Is There Any Association between Hirsutism and Serum Zinc Levels in Adolescents? Biological Trace Element Research, 198, 403-409. [Google Scholar] [CrossRef] [PubMed]
[27] Yosaee, S., Soltani, S., Esteghamati, A., Motevalian, S.A., Tehrani-Doost, M., Clark, C.C.T., et al. (2020) Effects of Zinc, Vitamin D, and Their Co-Supplementation on Mood, Serum Cortisol, and Brain-Derived Neurotrophic Factor in Patients with Obesity and Mild to Moderate Depressive Symptoms: A Phase II, 12-Wk, 2 × 2 Factorial Design, Double-Blind, Randomized, Placebo-Controlled Trial. Nutrition, 71, Article 110601. [Google Scholar] [CrossRef] [PubMed]
[28] Wang, R., Huang, K., Wang, M., Zou, W., Huang, Y., Jiang, W., et al. (2025) Efficacy of Dietary Supplements as an Adjunctive Therapy for Polycystic Ovary Syndrome: An Umbrella Meta-Analysis. Frontiers in Nutrition, 12, Article ID: 1705284. [Google Scholar] [CrossRef
[29] Torshizi, F.F., Heravi, R.M. and Javadmanesh, A. (2024) Effect of Zinc on Blood Biochemical and mTOR Gene Expression in Rats with Polycystic Ovarian. Biological Trace Element Research, 203, 3793-3802. [Google Scholar] [CrossRef] [PubMed]
[30] Fazel Torshizi, F., Chamani, M., Khodaei, H.R., Sadeghi, A.A., Hejazi, S.H. and Heravi, R.M. (2020) The Effects of Zinc Methionine on Reproductive and Thyroid Hormones in Rats with Polycystic Ovarian Syndrome. Advanced Biomedical Research, 9, Article No. 57. [Google Scholar] [CrossRef] [PubMed]
[31] Schlegel, P. and Windisch, W. (2006) Bioavailability of Zinc Glycinate in Comparison with Zinc Sulphate in the Presence of Dietary Phytate in an Animal Model with 65zn Labelled Rats. Journal of Animal Physiology and Animal Nutrition, 90, 216-222. [Google Scholar] [CrossRef] [PubMed]
[32] Srnovršnik, T., Pinter, B., Horvat, M., Snoj Tratnik, J., Falnoga, I., Mazej, D., et al. (2025) Association of Trace Elements with Polycystic Ovary Syndrome in Women—A Case-Control Study. Metabolites, 15, 79-104. [Google Scholar] [CrossRef] [PubMed]
[33] Bizoń, A., Słowiak, A., Franik, G., Biernacka-Bartnik, A. and Madej, P. (2020) Zinc, Copper, Sirtuin 1 Concentration, and Glucose Metabolism Parameters in the Blood of Women with Polycystic Ovary Syndrome. Gynecological Endocrinology, 36, 951-954. [Google Scholar] [CrossRef] [PubMed]
[34] Oestreicher, P. and Cousins, R.J. (1985) Copper and Zinc Absorption in the Rat: Mechanism of Mutual Antagonism. The Journal of Nutrition, 115, 159-166. [Google Scholar] [CrossRef] [PubMed]
[35] Osadchyi, V., Van Antwerp, S.N. and Vredenburgh, J. (2025) Zinc-Induced Copper Deficiency Myeloneuropathy Masquerading as Paraneoplastic Syndrome: A Case Report. Cureus, 17, e82995. [Google Scholar] [CrossRef] [PubMed]
[36] Solomons, N.W. and Jacob, R.A. (1981) Studies on the Bioavailability of Zinc in Humans: Effects of Heme and Nonheme Iron on the Absorption of Zinc. The American Journal of Clinical Nutrition, 34, 475-482. [Google Scholar] [CrossRef] [PubMed]
[37] 郭小芳, 文希, 李平. 二甲双胍片与硫酸锌片联合治疗对多囊卵巢综合征患者内分泌功能的影响[J]. 中国医院用药评价与分析, 2017, 17(4): 474-476.
[38] Amos, A. and Razzaque, M.S. (2022) Zinc and Its Role in Vitamin D Function. Current Research in Physiology, 5, 203-207. [Google Scholar] [CrossRef] [PubMed]
[39] Jamilian, M., Maktabi, M. and Asemi, Z. (2017) A Trial on the Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome. Archives of Iranian Medicine, 20, 640-645.
[40] Dhar, S., Yadav, R. and Tomar, A. (2024) Serum Zinc Levels in Women with Polycystic Ovarian Syndrome Are Lower as Compared to Those without Polycystic Ovarian Syndrome: A Cohort Study. Journal of Human Reproductive Sciences, 17, 25-32. [Google Scholar] [CrossRef] [PubMed]